학술논문
HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
Document Type
article
Author
Source
Indian Heart Journal, Vol 73, Iss 1, Pp 74-76 (2021)
Subject
Language
English
ISSN
0019-4832
Abstract
Background: HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation. Methods: This was a prospective, cross sectional and observational study conducted on Hydroxychloroquine (HCQ) among Healthcare Workers (HCWs) at Max Super Speciality Hospital, Saket, New Delhi, India. A 3-lead ECG (only limb leads, it does not require chest leads) was performed. The QTc cut offs were pre decided, QTC